Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Metabolic Myopathies, Rhabdomyolysis and Exercise Intolerance Panel PreventionGenetics, part of Exact Sciences United States | 239 | 158 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 466 | 297 |
|
Glycogen Storage Disease and Disorders of Glucose Metabolism Panel PreventionGenetics, part of Exact Sciences United States | 33 | 33 |
|
Lafora Disease via the NHLRC1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Baylor Genetics United States | 1 | 397 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 414 | 800 |
|
Hereditary ataxias panel_v.2.0 CGC Genetics Unilabs Portugal | 1 | 427 |
|
CGC Genetics Unilabs Portugal | 1 | 837 |
|
Movement diseases (WES based NGS panel of 931 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 10 | 930 |
|
Neurodegenerative panel _v.2.0 CGC Genetics Unilabs Portugal | 15 | 207 |
|
CGC Genetics Unilabs Portugal | 1 | 759 |
|
Comprehensive Epilepsy Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 234 | 240 |
|
Glycogenosis (WES based NGS panel of 28 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 28 |
|
Hereditary dementias (WES based NGS panel of 44 genes, including analysis of CNVs) CGC Genetics Unilabs Portugal | 1 | 44 |
|
Alzheimer's and other dementias panel_v.2.0 CGC Genetics Unilabs Portugal | 1 | 20 |
|
Epilepsies (deletion/duplication analysis on CHRNA4, CHRNB2, EPM2A, KCNQ1, KCNQ3 and NHLRC1 genes) CGC Genetics Unilabs Portugal | 1 | 6 |
|
Epilepsy, progressive myoclonic 2B (Lafora) (sequence analysis of NHLRC1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Mendelics Brazil | 1 | 240 |
|
HEREDITARY ATAXIAS EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 1202 |
|
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 139 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.